I am a fellow investor in Genmab for more than 10 years and therefore an avid reader of any information concerning the stock. I subscribe to Blogbuster and read, via Google translate, the Proinvestor forum. Although I am not interested in becoming an active member, lacking detailed knowledge, I do have a question which could be of interest to the forum. Perhaps you could answer or post this view on the forum.

My question concerns the short-selling and possible strategy:

There is possibly a huge disconnect between the market-value and the intrinsic-value: some suggest a takeout-value 4-times as high,
ownership is concentrated with large parties: > 60% in firm hands, not willing to sell for anything less than the intrinsic-value,
Big Farma is in need to replenish their pipeline, paying top-dollar for takeovers,
Genmab could be next/ will be next....

Now suppose I am a big player and I sell short. I use the proceeds to buy a bull product: turbo, cfd, and what not:

The short-selling keeps the share-price under pressure: I can buy my turbo, bull certificates even lower...(or even regular shares if I want to build a position)
If the share drops even more, I lose on the turbo, but I can close my short position,
If the share rises, the gains on the turbo are much higher than the loss on the short position,
If there is a takeover, I can gain even more by creating/contributing to a short-squeeze and then selling my turbo at the self created peak and closing the short position.

I hope I did not make a total fool of myself by asking this question.

Wishing you, your forum, an Genmab all the best from the Netherlands",

XXXXXXXX